← Evidence map

ArticleClinicoEconomics and outcomes research : CEOR2019

North American cost analysis of brand name versus generic drugs for the treatment of glaucoma.

Monali S Malvankar-Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31908505